An interventional study of Stellate Ganglion Block in Intracranial Aneurysm, sponsored by General Hospital of Ningxia Medical University. Status unknown at 1 site in China. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2016-05-20.
Sponsored by General Hospital of Ningxia Medical University · Not applicable, Interventional, and Prevention
To investigate whether stellate ganglion block is helpful to brain protection during cranial aneurysm surgery
The vasospasm after cranial aneurysm surgery have a higher incidence, but not have an ideal treatment method. At present, the medical treatment is very limited effect to prevent the perioperative cerebral ischemia.Stellate ganglion block （SGB）is an effective and well-tolerated approach to the treatment of CVS in various clinical settings.Resent study indicated that SGB has a protective effect on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.Therefore,we hypothesized that the preoperative SGB would be a effective treatment for improvement of vasospasm after cranial aneurysm surgery.
136 studies on the registry are indexed under Ganglion Cysts; 28 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 101 interventional studies indexed under Ganglion Cysts.
Browse Ganglion Cysts studies →General Hospital of Ningxia Medical University is the lead sponsor of 102 studies on the registry; 39 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Experimental patients will receive a stellate ganglion block with 0.25% ropivacaine 6-8mL on the right side at the level of the sixth cervical vertebrae (C6) before surgery.Then the catheter will be attached to a single use patient-controlled analgesia pump containing 0.2% ropivacaine 150 mL, which will be infused at 2 mL/h.
Drug: Stellate Ganglion Block
In the control group, every thing will be conducted as a matter of routine without intervention.
stellate ganglion block will be administered using either 6-8mL saline (Group 1) or 0.25% ropivacaine 6-8mL (Group 2)
Also known as: Local anesthesia with low concentration ropivacaine
The incidence of cerebral vasospasm
The occurrence of cerebral vasospasm will be diagnosed by using of the transcranial doppler instrument.
Time frame: Change from baseline at 2hour,6hour,1day,3day,and 7day after aneurysm surgery
Perioperative cerebral oxygen metabolism
Cerebral oxygen metabolism will be monitored through jugular venous oxygen saturation (SjVO2) and cerebral extraction rate of oxygen (CERO2), and measured by blood gas analysis at each time point, the latter will be calculated using the formula: CaO2 = (Hb\*1.38\*SaO2) + (0.003\*PaO2); CvO2 = (Hb\*1.38\*SjvO2) + (0.003\*PjvO2); CERO2 = (CaO2-CvO2)/CaO2 where CaO2 is arterial oxygen content, Hb is arterial hemoglobin concentration, SaO2 is arterial oxygen saturation, PaO2 is the arterial partial pressure of oxygen, CvO2 is mixed venous oxygen content and PjvO2 is the jugular venous partial pressure of oxygen.
Time frame: Change from baseline at 2hour,6hour,1day,3day,and 7day postoperatively
The difference of plasma endothelin, melatonin, and S100-β protein level between two groups at each time point
A 5-mL jugular venous blood sample will be taken at each time point, centrifuged at 3,000 rpm for 25 min, and kept in a freezer at -80°C until analysis. the concentrations of plasma endothelin, melatonin, and S100-β protein will be measured using enzyme-linked immunosorbent assays.
Time frame: Change from baseline at 2hour,6hour,1day,3day,and 7day postoperatively
Postoperative cognitive function
The postoperative cognitive function will be measured by using of the mini-mental state examination (MMSE).
Time frame: Change from baseline at 2hour,6hour,1day,3day,and 7day after aneurysm surgery
The postoperative recovery quality
The postoperative recovery quality will be evaluated by using of the Post-operative Quality Recovery Scale (PQRS)
Time frame: Change from baseline at 2hour,6hour,1day,3day,and 7day postoperatively
This study is status unknown, as verified in May 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
General Hospital of Ningxia Medical University